A Study of Adherence Scores and Patient Satisfaction Scores to Oral Chemotherapy for Patients followed by a Pharmacist in an Outpatient Cancer Center

Overview

About this study

The purpose of this study is to measure adherence scores to oral chemotherapy for patients educated and followed by a clinic-based pharmacist in an outpatient cancer center versus patients not followed by a pharmacist using patient reported adherence rates.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who are currently taking oral chemotherapy for at least 30 days but no more than 180 days

Exclusion Criteria: 

  • Patient who are taking oral chemotherapy as part of a clinical trial or who have been on oral chemotherapy for less than 30 days.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Andrea McNatty, Pharm.D., R.Ph.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions